Arfolitixorin: Support From FDA, Doctors Are Excited About The Drug & How It Works

Arfolitixorin: Support From FDA, Doctors Are Excited About The Drug & How It Works

Annual-Meeting

4 months
81 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Anders Rabbe CEO Of Isofol Medical Discusses Arfolitixorin: Support From FDA, Doctors Are Excited About The Drug & How It Works.
Up Next Autoplay
BEACON Trial: What's Next?
BEACON Trial: What's Next?
Category: Colorectal Cancer
2 Views
Cancer-News 2 days
Phase 3 BEACON CRC Trial
Phase 3 BEACON CRC Trial
Category: Colorectal Cancer
35 Views
Cancer-News 2 days
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Category: Colorectal Cancer
26 Views
Cancer-News 2 weeks
How does this affect treatment?
How does this affect treatment?
Category: Colorectal Cancer
8 Views
Cleveland Clinic 4 weeks
Is this truly safe?
Is this truly safe?
Category: Colorectal Cancer
1 Views
Cleveland Clinic 4 weeks
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Category: Colorectal Cancer
10 Views
Cleveland Clinic 4 weeks
IDEA: Factors to consider
IDEA: Factors to consider
Category: Colorectal Cancer
2 Views
moasc 1 month
The impact the IDEA data will have on clinicians
The impact the IDEA data will have on clinicians
Category: Colorectal Cancer
1 Views
moasc 1 month
IDEA: 3 vs. 6 months
IDEA: 3 vs. 6 months
Category: Colorectal Cancer
1 Views
moasc 1 month
The IDEA Collaboration
The IDEA Collaboration
Category: Colorectal Cancer
4 Views
moasc 1 month